Phase I immunology clinical trial starts growth rate

Percentage change in Phase I immunology clinical trial starts over a specified period.

Unit Percent Industry Pharmaceuticals

Records
2
Regions
1
Period
2024–2025
Sources
1
Verification 2 verified data points Verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Phase I immunology clinical trial starts growth rate

Global, 2024–2025

1 observation
-13% Global · 2024–2025 · IQVIA · full record
Source: IQVIA · CC BY 4.0 · statorigin.org

Every record

All records

2 records · 1 region · 2024–2025

Phase I immunology clinical trial starts growth rate: every record, grouped by region, newest first.
Period Value Source Type
Global 2 records
2024–2025 -13% IQVIA · 31 Dec 2025 actual
2024–2025 -13% IQVIA · 31 Dec 2025 actual

Primary documents

Sources

2 documents. Each links to the publisher's own copy.

Document Publisher Published Data points
Global R&D Trends 2026 IQVIA 1
Global R&D Trends 2026 IQVIA 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Phase I immunology clinical trial starts growth rate. Retrieved from https://statorigin.org/indicators/phase-i-immunology-clinical-trial-starts-growth-rate